<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="../../web/xslt/drug-table.xslt"?><drug name = "levothyroxine inj VIAL>
<dose><value>12.5 - 100</value>
<value>1 - 3</value>
<value>50 - 200</value>
<value>5 - 8</value>
<value>1 - 5</value>
<value>200 - 500</value>
<value>20</value>
<value>10</value>
</dose><route><value>IM</value>
<value>IV</value>
</route><form><value>inj VIAL</value>
</form><drug><value>levothyroxine inj VIAL</value>
</drug><strength><value>500 mcg</value>
</strength><frequency><value>DAILY</value>
<value>Q24H.</value>
<value>ONCE</value>
<value>CONTINUOUS</value>
</frequency><instruction><value></value>
<value>Administer by continuous infusion.</value>
</instruction><volume><value></value>
</volume><units><value>mcg/day</value>
<value>mcg/kg/day</value>
<value>mcg/kg/dose</value>
<value>mcg/kg</value>
<value>mcg</value>
<value>mcg/hour</value>
</units><additionalnotes><value></value>
<value>Daily for 7 to 10 days for TSH Suppression Therapy.</value>
<value>Continue treatment until patient stable and oral dosing is feasible.</value>
<value>Dosing approximately 50 - 75% of the oral dose.</value>
<value>Initial Dose: Myxedema Coma. </value>
<value>BOLUS DOSE, follow with infusion (10 mcg/hour).</value>
</additionalnotes><population><value>ADULT</value>
<value>NEONATES</value>
<value>INFANTS/CHILDREN</value>
<value>ADULTS</value>
</population><indicationprn><value></value>
</indicationprn><backgroundinformation><value></value>
</backgroundinformation><prninformation><value></value>
</prninformation><ahsformularystatus><value>Formulary with Usage guidelines.</value>
</ahsformularystatus><ahfsname><value>Thyroid Agents</value>
</ahfsname><highalert><value></value>
</highalert><maximumprndose><value></value>
</maximumprndose></drug>